The role of angiotensin II in nonalcoholic steatohepatitis

Molecular and Cellular Endocrinology
E Matthew MorrisR Scott Rector

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now considered the most prevalent chronic liver disease, affecting over 30% of the US adult population. NAFLD is strongly linked to insulin resistance and is considered the hepatic manifestation of the metabolic syndrome. Activation of the renin-angiotensin-aldosterone system (RAAS) is known to play a role in the hypertension observed in the metabolic syndrome and also is thought to play a central role in insulin resistance and NAFLD. Angiotensin II (AngII) is considered the primary effector of the physiological outcomes of RAAS signaling, both at the systemic and local tissue level. Herein, we review data describing the potential involvement of AngII-mediated signaling at multiple levels in the development and progression of NAFLD, including increased steatosis, inflammation, insulin resistance, and fibrosis. Additionally, we present recent work on the potential therapeutic benefits of RAAS and angiotensin II signaling inhibition in rodent models and patients with NAFLD.

References

Jan 1, 1997·Hypertension·K K GriendlingR W Alexander
Apr 1, 1997·Endocrinology·B H JonesN Moustaid
Sep 1, 1999·Kidney International·S KatoH S MacKenzie
Jan 22, 2000·Annals of Internal Medicine·S BellentaniC Tiribelli
Nov 18, 2000·The New England Journal of Medicine·H Tilg, A M Diehl
Apr 12, 2001·Seminars in Liver Disease·Y Falck-YtterA J McCullough
May 23, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M Ruiz-OrtegaJ Egido
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J CrespoF Pons-Romero
Jan 30, 2002·Progress in Lipid Research·Simon Eaton
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiJanus P Ong
Jun 18, 2002·Nature Medicine·Norikazu MaedaYuji Matsuzawa
Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Nov 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Eva TomasNeil B Ruderman
Apr 24, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elena M V de CavanaghCesar G Fraga
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brent A Neuschwander-Tetri, Stephen H Caldwell
May 30, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ramón BatallerRichard A Rippe
Jul 16, 2003·The American Journal of the Medical Sciences·Ursula C BrewsterMark A Perazella
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason M HuiJacob George
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mercedes Pérez-CarrerasJosé A Solis-Herruzo
Nov 5, 2003·The Journal of Clinical Investigation·Ramon BatallerDavid A Brenner
Nov 12, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·T-J HsiaoJ-D Wang
Dec 4, 2003·Biochemical Society Transactions·S Miwa, M D Brand
Apr 15, 2004·American Journal of Physiology. Endocrinology and Metabolism·Jianmin RanMitsuru Adachi
Jun 24, 2004·American Journal of Physiology. Endocrinology and Metabolism·Jianmin RanMitsuru Adachi
Jul 3, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Daqing GaoAnna Mae Diehl
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ariel E FeldsteinGregory J Gores
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shiro YokohamaKimihide Nakamura
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Feb 16, 2005·Biochemical Pharmacology·Hans NohlKatrin Staniek

❮ Previous
Next ❯

Citations

Apr 6, 2013·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Jia XiaoGeorge L Tipoe
Dec 25, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Salvatore PettaUNKNOWN Special Interest Group on Personalised Hepatology of Italian Association for Study of Liver AISF
Apr 19, 2015·Clinics and Research in Hepatology and Gastroenterology·Mustafa CengizGulbanu Erkan
Jun 7, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·George B GohSrinivasan Dasarathy
Oct 4, 2015·Trends in Molecular Medicine·Giovanni MussoRoberto Gambino
Oct 21, 2016·Expert Review of Gastroenterology & Hepatology·Elham AhmadianMohammad Ali Eghbal
Nov 1, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Phunchai CharatcharoenwitthayaTawesak Tanwandee
Nov 18, 2016·Scientific Reports·Anaïs BisonRosa-Maria Guéant-Rodriguez
Jun 20, 2017·Experimental Physiology·Eliete Dalla Corte FrantzAntonio Claudio Lucas Nobrega
May 8, 2018·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takumi KawaguchiTakuji Torimura
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Oct 13, 2017·Journal of Diabetes and Metabolic Disorders·Abdulmonim A AlqasimGhada E Esheba
Dec 22, 2017·Journal of the Endocrine Society·Aditi KumarAngela R Subauste
Sep 22, 2019·International Journal of Environmental Research and Public Health·Valerio RosatoMarcello Persico
Jan 20, 2017·Oxidative Medicine and Cellular Longevity·Valéria Nunes-SouzaLuiza A Rabelo
Oct 24, 2014·World Journal of Gastroenterology : WJG·Bülent Baran, Filiz Akyüz
Mar 12, 2015·World Journal of Gastroenterology : WJG·Meghan PrinGebhard Wagener
Apr 1, 2020·Archives of Physiology and Biochemistry·Nisha SharmaAnil Bhanudas Gaikwad
Jun 13, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masato FuruhashiTetsuji Miura
Jul 27, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jianghua ZhouJingjing Cai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.